Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors.
Seijas-Amigo J, Gayoso-Rey M, Mauriz-Montero MJ, Suarez-Artime P, Casas-Martinez A, Dominguez-Guerra M, Gonzalez-Freire L, Estany-Gestal A, Codero-Fort A, Rodriguez-Mañero M, Gonzalez-Juanatey JR; e investigadores MEMOGAL. Seijas-Amigo J, et al. Among authors: gayoso rey m. Clin Investig Arterioscler. 2022 Sep-Oct;34(5):245-252. doi: 10.1016/j.arteri.2022.01.003. Epub 2022 Feb 3. Clin Investig Arterioscler. 2022. PMID: 35287972 Free PMC article. English, Spanish.
Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice.
Gayoso-Rey M, Díaz-Trastoy O, Romero-Ventosa EY, García-Beloso N, González-Freire L, Lorenzo-Lorenzo K, Mantiñán-Gil B, Palmeiro-Carballeira R, Bravo-Amaro M, López-Gil-Otero MDM, Martínez-Reglero C, Crespo-Diz C, Fernández-Catalina P, Piñeiro Corrales G. Gayoso-Rey M, et al. Clin Ther. 2021 Apr;43(4):e111-e121. doi: 10.1016/j.clinthera.2021.02.002. Epub 2021 Mar 9. Clin Ther. 2021. PMID: 33712271
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World-MEMOGAL Study.
Seijas-Amigo J, Mauriz-Montero MJ, Suarez-Artime P, Gayoso-Rey M, Estany-Gestal A, Casas-Martínez A, González-Freire L, Rodriguez-Vazquez A, Pérez-Rodriguez N, Villaverde-Piñeiro L, Castro-Rubinos C, Espino-Faisán E, Rodríguez-Mañero M, Cordero A, González-Juanatey JR; Investigadores MEMOGAL. Seijas-Amigo J, et al. Among authors: gayoso rey m. Am J Cardiovasc Drugs. 2023 Sep;23(5):583-593. doi: 10.1007/s40256-023-00604-6. Epub 2023 Aug 23. Am J Cardiovasc Drugs. 2023. PMID: 37612529 Free PMC article.
Regorafenib and trifluridine/tipiracil in real clinical practice.
García-Beloso N, Romero-Ventosa EY, Gayoso-Rey M, López-López A, Robles-Torres D, de Castro NM, Piñeiro-Corrales G. García-Beloso N, et al. Among authors: gayoso rey m. J Cancer Res Ther. 2022 Dec;18(Supplement):S367-S373. doi: 10.4103/jcrt.JCRT_1316_20. J Cancer Res Ther. 2022. PMID: 36510990 Free article.
Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care.
Romero-Ventosa EY, Gayoso-Rey M, Samartín-Ucha M, Lamas-Domínguez P, Rubianes-González M, Rodríguez-Lorenzo D, Rodríguez-Vázquez MH, García-Comesaña J, Piñeiro-Corrales G. Romero-Ventosa EY, et al. Ther Innov Regul Sci. 2018 Jan;52(1):94-99. doi: 10.1177/2168479017716716. Epub 2017 Jun 28. Ther Innov Regul Sci. 2018. PMID: 29714617
Factors associated with patient satisfaction in an outpatient hospital pharmacy.
Martínez-López-de-Castro N, Álvarez-Payero M, Martín-Vila A, Samartín-Ucha M, Iglesias-Neiro P, Gayoso-Rey M, Feijoo-Meléndez D, Casanova-Martínez C, Fariña-Conde M, Piñeiro-Corrales G. Martínez-López-de-Castro N, et al. Eur J Hosp Pharm. 2018 Jul;25(4):183-188. doi: 10.1136/ejhpharm-2016-001192. Epub 2017 Mar 16. Eur J Hosp Pharm. 2018. PMID: 31157016 Free PMC article.
Standardization Consensus of a Hospital Drug Database: An Efficient Tool.
Gayoso-Rey M, Romero-Ventosa EY, Leboreiro-Enríquez B, Álvarez-Sánchez MJ, Gonzalo LB, García-Comesaña J, Piñeiro-Corrales G. Gayoso-Rey M, et al. Ther Innov Regul Sci. 2020 Jan;54(1):85-92. doi: 10.1007/s43441-019-00032-2. Epub 2020 Jan 6. Ther Innov Regul Sci. 2020. PMID: 32008248
Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review.
García-Beloso N, Altabás-González I, Samartín-Ucha M, Gayoso-Rey M, De Castro-Parga ML, Salgado-Barreira Á, Cibeira-Badia A, Piñeiro-Corrales MG, González-Vilas D, Pego-Reigosa JM, Martínez-López de Castro N. García-Beloso N, et al. Among authors: gayoso rey m. Br J Clin Pharmacol. 2022 Feb;88(4):1529-1550. doi: 10.1111/bcp.15101. Epub 2021 Nov 2. Br J Clin Pharmacol. 2022. PMID: 34622969 Free article. Review.
12 results